EUVIMEDEUVIMED entdecken
Korrektur

Correction to “Recent Cutting‐Edge Designing Strategies for Mtb‐DHFR Inhibitors as Antitubercular Agents”

Chemical Biology & Drug Design · 2026-07 · 108 (1)

DOI: 10.1111/cbdd.70357 ↗

Kurz gefasst

Korrektur in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 09.07.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sonawane, N. G., Thakur, A., Pillai, A. K. S., Sharma, A., Gunjal, A. P., & Sharma, K. (2024). “Recent Cutting-Edge Designing Strategies for Mtb-DHFR Inhibitors as Antitubercular Agents.” Chemical Biology & Drug Design 104, no. 6: e70027. The affiliation of the authors Nitin Govind Sonawane, Amrita Thakur, Anil Kumar Sasidharan Pillai, and Amol Pandurang Gunjal was incorrect and has been corrected to Department of Physical Sciences, Amrita School of Engineering, Amrita Vishwa Vidyapeetham, Bengaluru Campus, India. The online version of this article has been corrected accordingly. We apologize for this error.

Zitieren

APA

(2026). Correction to “Recent Cutting‐Edge Designing Strategies for Mtb‐DHFR Inhibitors as Antitubercular Agents”. Chemical Biology & Drug Design, 108(1). https://doi.org/10.1111/cbdd.70357

Vancouver

Correction to “Recent Cutting‐Edge Designing Strategies for Mtb‐DHFR Inhibitors as Antitubercular Agents”. Chemical Biology & Drug Design. 2026;108(1). doi:10.1111/cbdd.70357

BibTeX
@article{euvimed2026,
  title = {Correction to “Recent Cutting‐Edge Designing Strategies for Mtb‐DHFR Inhibitors as Antitubercular Agents”},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {108},
  number = {1},
  doi = {10.1111/cbdd.70357}
}
Kostenlos starten →